Prognostic scores, such as the PRISM and APACHE II, have been established, predicting with reasonable accuracy the outcome of patients admitted to intensive care units (ICU). In keeping with previous reports, we found, however, that these scores failed to perform in a series of 28 recipients of hematopoietic auto-or allografts (BMT) who required ICU admission for reasons including respiratory (82%) and multi-organ (36%) failure. We therefore retrospectively analyzed the charts of these patients, evaluating predisposing factors and prognostic variables which might confound the validity of these ICU tools which in other clinical scenarios have proven so valuable. Of all the parameters tested, logistic analysis established the following as predictors for poor outcome: increased C-reactive protein (CRP) to Ͼ10 mg/dl (P ‫؍‬ 0.04), macroscopic hemorrhage (P ‫؍‬ 0.04), hypotension (mean arterial pressure Ͻ normal) (P ‫؍‬ 0.04) and GVHD у III (P ‫؍‬ 0.002). Most of these factors are not accounted for by the standard prognostic questionnaires. The development of an 'oncological' or 'post-BMT' risk of mortality score, taking into account these patients' specific clinical problems, might improve the risk assessment for this patient group, and might thus facilitate the timely recognition of those patients most in need of more intensive therapeutic measures. Bone Marrow Transplantation (2000) 25, Suppl. 2, S32-S34.
Peripheral blood stem cell and bone marrow transplantation (BMT) are associated with a substantial risk of potentially life-threatening complications such as systemic infection/sepsis, graft-versus-host disease (GVHD), capillary leakage syndrome (CLS) and organ failure, caused by the toxicity of the conditioning regimen, infection, GVHD, Correspondence: Dr W Nürnberger, Department of Pediatric Hematology and Oncology, Heinrich-Heine-University Medical Center, Moorenstraße 5, D-40225 Düsseldorf, Germany or combinations thereof. Much progress has been made in combatting these problems. Nonetheless, a number of authors have reported that, once BMT patients require intensive care support, their prognosis is dismal. [1] [2] [3] [4] [5] This is particularly true for patients with 'sepsis' and multi-organ failure (MOF). In this context, the term 'sepsis' is used to describe the concurrence of serious infection/persistent fever of unknown origin (FUO) and neutropenia. The ongoing, accurate assessment of the clinical state of post-BMT patients, ideally with the help of validated clinical scoring systems, ought to lead to a timely recognition of patients in need of more intensive care and therapy measures, and might thus improve their outcome. Unfortunately, the failure of prognostic scoring tools has repeatedly been demonstrated for oncological patients post BMT. 5, 6 Among a number of reasons for this may be the fact that most scores were conceived for the evaluation of patients upon hospital admission, and that specific problems of the post-transplant period are not accounted for or are not graded with respect to their respective importance in this very particular group of patients. In a single-center study we attempted to identify the prognostic relevance of some specific post-transplant problems, and their respective impact on survival after admission to the ICU.
Patients and methods
Of 180 patients who were transplanted in Düsseldorf between January 1989 and December 1998 (68 autologous, 70 allogeneic-related, 42 unrelated), 28 patients required ICU treatment during the first year post BMT. Written informed consent to the analysis of the medical data had been obtained prior to BMT. Conditioning and GVHD prophylaxis regimens varied with regard to patient age and underlying illness, but were performed in keeping with standard transplant procedures. The clinical data upon admission to the ICU were analyzed, including vital signs, blood biochemistries, microbiological and virological findings, and immediate therapeutic measures, such as vasopressor or mechanical renal or respiratory support. Further treatment intensification on the ICU was monitored.
The data were analyzed using contingency tables (SPSS program, release 7.5) with categorical data being analyzed H Bönig et al
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with the Pearson 2 test and continuous numeric data being calculated with Mann-Whitney's U test. A logistic regression analysis was conducted to determine independent prognostic variables. A P value Ͻ0.05 was regarded as significant.
Results

Admission to the ICU
Twenty-eight/180 (15.6%) of the pediatric BMT patient population required ICU treatment. These were 16 male, 12 female patients, aged 10 years 9 months (range 4 months to 18 years 9 months) (median (range). Five patients were recipients of autologous, 13 of allogeneically related 10 of unrelated grafts, thus the autologous BMT patients were slightly under-represented, the unrelated BMT patients slightly over-represented. Time of admission to the ICU was 61 (4-182) days post BMT. This rather late referral was consistent with the fact that only 3/28 patients were aplastic, and that 10/28 were thrombocyte-and 7/28 were erythrocyte-transfusion independent. Respiratory failure, necessitating mechanical ventilation was the most frequent cause of ICU referral (n = 23), followed by multi-organ failure (n = 10). Six patients were admitted to the ICU following cardiopulmonary resuscitation on the BMT ward.
Documented infections
Positive blood cultures for bacteria were found in three patients admitted on days ϩ3, ϩ10, and ϩ158 after BMT, viral infections were diagnosed in 10 patients after a median of 59 (4-231) days post-BMT. Rarer infectious agents identified included two Aspergillus sp. (days ϩ66, ϩ210) and one Toxoplasma (day ϩ51).
Figure 1
The percentage of patients with macroscopic hemorrhage is depicted as lightly shaded columns. The percentage of patients with a CRP Ͼ10 mg/dl is depicted as dark columns, among the patients with failure of 0-3 organ systems. Both high CRP and macroscopic hemorrhage were positively correlated with a higher number of failing organ systems.
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Macroscopic hemorrhage
At the time of admission to the ICU, 15/28 patients had macroscopic hemorrhage. This was strongly associated with the degree of GVHD and with Polyoma virus infection of the vesico-urethral tract.
Multiple organ failure (MOF)
Need for cardiac/circulatory support or for mechanical assistance of renal or respiratory function were each counted as failure of one organ system. Fifteen patients required support to only one organ system, five patients each had two-and three-organ failure. The number of failing organs correlated positively with the likelihood of patients having very high CRP (CRP у10 mg/dl) or macroscopic hemorrhage (Figure 1) .
Predictors of outcome
Fourteen/28 patients admitted to the ICU were able to return to the transplant ward. Of these, six were alive 122-408 weeks post BMT. Donor type seemed not to influence the discharge rate from ICU, but among the long-term survivors were no unrelated transplant recipients. Taking 'discharge from the ICU' as endpoint, logistic regression analysis identified a CRP Ͼ10 mg/dl (P = 0.04), macroscopic hemorrhage (P = 0.04), sub-normal mean arterial pressure (P = 0.04) and GVHD уIII (P = 0.002) as indicators of an adverse prognosis. Thus a CRP Ͼ10 mg/dl was seen in 9/14 of the patients who died on the ICU, but only in 4/14 who were eventually discharged (relative risk 2.3; 95% confidence interval 0.9-5.6). Macroscopic hemorrhage was observed in 10/14 patients who died on the ICU, and in 4/14 who did not (relative risk 2.2; 95% confidence interval 1.0-4.6). Vasopressor drugs (dopamine Ͼ5 g/kg BW× min, all other pressors) were required on admission in 7/14 patients who died on the ICU, and in 2/14 who left the ICU (relative risk 3.5; 95% confidence interval 0.9-14).
Discussion
The prognosis of BMT patients who require ICU support is currently viewed as rather poor. [1] [2] [3] [4] [5] In part, this may have to do with a failure to recognize early enough the BMT patients in need of ICU support. Prognostic scoring systems have been successfully used for the evaluation of the clinical state of severely ill patients. The failure of such tools in the scenario of post-BMT ICU admissions has, however, repeatedly been reported. 5, 6 We therefore analyzed the reasons for admission to the ICU, the clinical courses on the ICU, and the predictors of an adverse outcome of the 28/180 BMT recipients at the Heinrich-Heine University Bone Marrow Transplantation Center who needed ICU therapy.
On average, ICU admission was required approximately 2 months post BMT. This indicates that conditioningrelated toxicity, aplasia and the ubiquitous complications associated with the two, namely, infections, veno-occlusive disease of the liver, capillary leakage syndrome were generally quite successfully mastered. The relatively low number of bacterial infections leading to ICU transfers underscores the success of the antibiotic therapy, but also highlights the increasing relevance during the later post-BMT period of problematic infectious agents such as viruses and fungi. All together, the role of 'uncontrolled infections', or 'sepsis' at this stage after BMT remains rather strong, as is demonstrated by the more than two-fold increased risk of death on ICU for patients with CRP Ͼ10 mg/dl. One message this should teach us is that a thorough viral and fungal work-up may be a prerequisite for improved survival in patients at later stages post-BMT. We also see that other basic parameters, such as GVHD уIII, hemorrhage, hypotension, and MOF were related to outcome. All these parameters are readily assessable in all transplant centers.
Future studies should now aim at including these parameters in prognostic scores in order to improve the power of these tools for the assessment of post-BMT patients. Early recognition of patients with increasing need for clinical support, ideally with the help of prognostic scoring systems, might further improve the outcome of BMT recipients.
